Biotech & pharma
Studies evaluate micro-incision surgery for removal of advanced and complex kidney cancers
By By Jackie Carr | 30 Jul 2010
Non-human sugar in biotech drugs causes inflammation
By By Scott LaFee | 27 Jul 2010
12 new genes linked to type 2 diabetes
24 Jul 2010
Bt brinjal needs much further testing
22 Jul 2010
Genetically modified Bt brinjal should not be released in the market without a full assessment of its impact on health and the environment, argues Manu Sharma
Metabolic disease: researchers find cause and possible cure
16 Jul 2010
An international team of scientists has discovered the gene mutation responsible for a condition in which eye and brain development is severely disrupted in affected infants
Opening the gate to the cell's recycling center
15 Jul 2010
In cells, as in cities, disposing of garbage and recycling anything that can be reused is an essential service. In both city and cell, health problems can arise when the process breaks down.
Novel Indian discovery may end pain of daily insulin shots
13 Jul 2010
A team of Indian scientists has developed a novel form of insulin that could drastically reduce the suffering diabetics have to undergo in controlling their blood sugar
Government plans Rs10,000-crore VC fund for drug research
13 Jul 2010
The fund, to be set up as an independent asset management company under the PPP model, will have 15 per cent government participation while the rest will come from other investors.
Radiation device allows for targeted breast radiation to control cancer
By By Karen Shea | 13 Jul 2010
Biologists find new way to lower tumour risk in stem cell therapies
By By Kim McDonald | 08 Jul 2010
Novel artificial proteins boost industry and science
08 Jul 2010
By integrating artificial amino acids into proteins in our body, a process known as genetic code engineering, the qualities of proteins can be systematically improved
Insulin that doesn't need a fridge or a needle
07 Jul 2010
The new insulins could one day become the basis of treatments taken in pill form, eliminating the need for injections
Latest articles
Featured articles
Artemis II and the economic outlook for lunar infrastructure
By Axel Miller | 01 Apr 2026
Artemis II will test deep-space systems and support future lunar missions, shaping the next phase of the global space economy.
Synthetic diplomacy: The $50 billion mirage and the new era of market-moving deepfakes
By Cygnus | 30 Mar 2026
Synthetic diplomacy shows how deepfakes could trigger market volatility, highlighting the growing need for verification in global financial systems.
AI war shifts gears: chips, drones reshape global power
By Cygnus | 27 Mar 2026
AI competition is shifting as chips, drones and supply chains reshape global power, impacting tech, defense and business strategies.
Trump’s Iran strike delay lifts markets, but risks remain elevated
By Axel Miller | 24 Mar 2026
Trump’s Iran strike delay eased market fears, sending oil lower and lifting Sensex. Risks remain as geopolitical tensions continue.
The rise of the ‘ghost executive’: how autonomous AI agents are entering the C-suite
By Cygnus | 17 Mar 2026
Autonomous AI agents are influencing business decisions and reshaping leadership structures as companies adopt agentic AI systems in 2026.
The sky is closing: The end of the global crossroads
By Axel Miller | 16 Mar 2026
Middle East airspace disruptions are forcing airlines to reroute global flights, raising costs and reshaping aviation networks in 2026.
Living in the “New Gulf”: how conflict is reshaping cities and infrastructure
By Cygnus | 16 Mar 2026
Gulf states are redesigning infrastructure, air defenses and aviation networks as regional tensions reshape urban resilience strategies.
The Petro-Tech Pivot: Why Your Next Phone Is Built on Shifting Sands
By Cygnus | 12 Mar 2026
Rising crude prices are reshaping electronics manufacturing as petrochemical costs drive pressure across the global tech supply chain.
Hardened compute: The rise of the data bunker
By Axel Miller | 11 Mar 2026
Explore how AI demand and geopolitical risk are driving investment in fortified data centers worldwide.


